While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions. Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Mid-Atlantic region through the speed and cost-effectiveness of medical repurposing.
Our events and research within the the Mid-Atlantic Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live! for Rare Diseases 2020
Five finalists from the US competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.
CureAccelerator Live! for Rare Diseases 2019
Three finalists from the US and Italy competing for up to $50,000 to fund their repurposing clinical trials impacting rare disease patients.
CureAccelerator Live! for the Developing World 2019
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.
CureAccelerator Live! for the Mid-Atlantic 2018
Four finalists from Mid-Atlantic institutions competing for up to $50,000 to fund their groundbreaking repurposing clinical trials.
Current Mid-Atlantic Research Projects
Completed Mid-Atlantic Research Projects
(in the past 3 years)